
DELTA GOLD TECHNOLOGIES LIMITED — Investor Relations & Filings
DELTA GOLD TECHNOLOGIES LIMITED is a research-driven technology company focused on developing intellectual property (IP) for the quantum computing (QC) sector. The company's core innovation is centered on leveraging the unique surface state properties of nano-scale gold to create novel solutions for quantum computing applications. This proprietary technology forms the basis of its IP portfolio. The company's primary business model involves generating revenue through the licensing of its specialized IP to other enterprises operating in the quantum technology field.
Recent filings
Browse filings by year
2 yearsFinancials
We couldn't load the financials
No data available yet
We have extracted financials for DELTA GOLD TECHNOLOGIES LIMITED, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno…
|
950220 | US | Professional, scientific and te… |
|
Neovacs
Biotech firm developing immunotherapies and investing in Bi…
|
ALNEV | FR | Professional, scientific and te… |
|
NervGen Pharma Corp.
Clinical-stage biotech developing treatments to promote ner…
|
NGEN | CA | Professional, scientific and te… |
|
NEUREN PHARMACEUTICALS LIMITED
Develops innovative therapies for rare neurodevelopmental d…
|
NEU | NZ | Professional, scientific and te… |
|
NEURIZON THERAPEUTICS LIMITED
Clinical-stage developer of mTOR modulators for ALS and neu…
|
NUZ | AU | Professional, scientific and te… |
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Develops peptide-based therapeutics for neurodegenerative a…
|
NSB | AU | Professional, scientific and te… |
|
NEUROTECH INTERNATIONAL LIMITED
Clinical-stage biopharmaceutical company developing pediatr…
|
NTI | AU | Professional, scientific and te… |
|
NewAmsterdam Pharma Co N.V.
A clinical-stage biopharma developing therapies for metabol…
|
NAMS | NL | Professional, scientific and te… |
|
NEXALIS THERAPEUTICS LTD
Develops small molecule therapies for chronic inflammatory …
|
NX1 | AU | Professional, scientific and te… |
|
NextGen Biomed Ltd.
Develops novel therapeutic delivery systems and pain-free a…
|
NXGN | IL | Professional, scientific and te… |
DELTA GOLD TECHNOLOGIES LIMITED via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35740/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35740 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35740 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35740 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35740}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DELTA GOLD TECHNOLOGIES LIMITED (id: 35740)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.